Corrigendum: A Multi-Mode Bioactive Agent Isolated From Ficus Microcarpa L. Fill. With Therapeutic Potential for Type 2 Diabetes Mellitus

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00643
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Ficus Deltoidea: A Potential Alternative Medicine for Diabetes Mellitus

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Aqueous Bark Extract of Cinnamomum Zeylanicum: A Potential Therapeutic Agent for Streptozotocin- Induced Type 1 Diabetes Mellitus (T1DM) Rats

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2012English

Challenges to Hemoglobin A1c as a Therapeutic Target for Type 2 Diabetes Mellitus

Journal of General and Family Medicine
2019English

Pmd13 - Prevalence of Isolated Hypertension Among Outpatients With Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Antibody-Mediated Oral Delivery of Therapeutic DNA for Type 2 Diabetes Mellitus

Biomaterials Research
MedicineBiomaterialsCompositesBiomedical EngineeringCeramics
2018English

Peripheral Blood microRNA-15a Is a Potential Biomarker for Type 2 Diabetes Mellitus and Pre-Diabetes

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Bromocriptine as a Potential Glucose-Lowering Agent for the Treatment of Prolactinoma With Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2019English

Momordica Charantia for Type 2 Diabetes Mellitus

Cochrane Database of Systematic Reviews
2012English

Bioactive Components From Ficus Glomerata

Pure and Applied Chemistry
ChemistryChemical Engineering
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy